Tag: S&P 500

  • Boston Scientific Stock Is on Pause. Its Earnings Could Get It Moving Higher Again

    Boston Scientific Stock Is on Pause. Its Earnings Could Get It Moving Higher Again

    Boston Scientific Corp. (NYSE: BSX), a leading global medical device manufacturer, is facing an unusual period of stagnation. Known for delivering consistent performance over the years, the company’s stock has treaded water for the last six months. But with the release of its second-quarter earnings scheduled for Wednesday, investors and analysts alike are watching closely for signs of renewed momentum.

    Boston Scientific’s stock has historically been a favorite among long-term investors, with a solid track record of innovation in minimally invasive medical technologies. Over the past five years, BSX has significantly outperformed many of its peers in the medtech sector, driven by robust product pipelines and strategic acquisitions.

    However, since January 2025, the stock has shown little movement—hovering around the $66 to $70 range. This is despite broader market indices, including the S&P 500 and the Nasdaq Composite, reaching new highs fueled by strong tech and healthcare performance.

    Market analysts attribute the recent pause in momentum to a combination of valuation concerns and investor wait-and-see behavior ahead of earnings. “Boston Scientific is not underperforming—it’s consolidating,” said Linda Corrigan, Senior HealthTech Analyst at Fairview Investments. “Investors are waiting for a new catalyst.”

    That catalyst could come in the form of Boston Scientific’s Q2 earnings report, which is expected before the market opens on Wednesday.

    Wall Street consensus estimates forecast revenue of $3.77 billion for the quarter, up 9.3% year-over-year, and earnings per share (EPS) of $0.61, compared to $0.53 in Q2 2024. The company has beaten EPS estimates in 8 of the last 10 quarters, and analysts are optimistic it will continue that trend.

    “The real story will be in the company’s guidance and commentary on growth drivers like the Watchman FLX Pro, Farapulse, and recent expansion in Asia-Pacific markets,” said John Nathan, Equity Research Director at Harding Wealth. “If they deliver a solid beat and raise, BSX could break out of its holding pattern.”

    Boston Scientific continues to benefit from its diversified product offerings across cardiology, urology, neuromodulation, and endoscopy. The Watchman heart device and Farapulse pulsed field ablation system remain two of its most closely watched products, with the latter recently gaining traction in Europe and awaiting wider U.S. adoption.

    Moreover, the company’s $3.7 billion acquisition of Axonics earlier this year has expanded its footprint in sacral neuromodulation and is expected to be accretive to earnings by late 2025.

    In its last earnings call, CEO Mike Mahoney emphasized “strong momentum across our growth platforms” and hinted at further investment in AI-driven diagnostics and robotic-assisted technologies—an area Boston Scientific is expected to ramp up through 2026.

    Despite the flat trading pattern, institutional interest in BSX remains strong. According to Bloomberg data, over 68% of the float is held by institutions, including major players like Vanguard, BlackRock, and T. Rowe Price.

    The stock currently trades at a forward price-to-earnings (P/E) ratio of 24.5, roughly in line with the sector average. Some analysts believe this leaves room for upside if the company can deliver a strong beat and raise guidance.

    Technical analysts note a key resistance level at $71.50. A strong earnings report could push the stock through this ceiling, with bullish targets around $75 to $78 in the near term.

    Boston Scientific is at a critical juncture. While its fundamentals remain strong and its long-term outlook is bright, the next few days could determine whether BSX resumes its upward climb or continues to linger in limbo. Wednesday’s earnings report will be a major inflection point for the stock—and possibly for investors seeking medtech exposure in a high-growth, post-pandemic landscape.

  • The S&P 500 ended the day just shy of a $9.8 trillion comeback

    The S&P 500 ended the day just shy of a $9.8 trillion comeback

    The S&P 500 on Thursday flirted with closing at an all-time high, vying to complete a whirlwind roundtrip that saw the benchmark US stock index shed and then regain roughly $9.8 trillion in market value across just four months.

    The S&P 500 has been on a roller coaster ride this year as President Donald Trump’s trade policy has jolted markets.

    The S&P 500 hit its last record high on February 19 before dropping as low as 18.9% by early April as tariff confusion rocked markets.

    The index has soared more than 23% since hitting its low point on April 8, in what has been a remarkable come back from the precipice of a bear market.

    US stocks were higher on Thursday. The Dow closed higher by 404 points, or 0.94%. The broader S&P 500 gained 0.8% and the tech-heavy Nasdaq Composite rose 0.97%.

    The S&P 500 briefly rose above its February record high during trading but fell below that level by the closing bell. The index needed to finish the day with a gain of 0.86% or more to officially notch a record high.

    The Nasdaq on Thursday briefly rose above its previous record in December but similarly finished below the mark needed to notch a record high. The tech-heavy index dropped into a bear market in early April before surging into a new bull market and gaining 32%.

    Stocks had pushed higher on Thursday amid a flurry of economic data, including a downward revision to how much the economy contracted in the first quarter.

    That revised data is “backward looking,” and markets were higher on Thursday because they have already priced in the turmoil from earlier this year, Paul Stanley, chief investment officer at Granite Bay Wealth Management, said in an email.

    “The market is betting on continued progress on trade and a de-escalation of tensions in the Middle East is giving investors confidence,” Stanley said.

    While the S&P 500 and Nasdaq have recovered, the Dow is still 3.75% away from its record high set in December. The Dow this year has been weighed down by stocks like UnitedHealth Group (UNH), which is down 40%.

    A $9.8 trillion recovery

    At its low on April 8, the S&P 500 had shed $9.8 trillion in market value since its record high on February 19, according to FactSet data. The index is set to recover all of that market value as it tests a new record high.

    Wall Street analysts are mixed on whether the S&P 500 can grind higher, or whether its return to record highs means there’s more downside to come.

    As tensions in the Middle East have settled, the focus returns to Trump’s agenda. Lawmakers hope to deliver the president’s budget bill to his desk by July 4, and his administration’s deadline for trade deals is July 9.

    “Meaningful progress on any of the two matters can bolster equities to fresh records,” José Torres, senior economist at Interactive Brokers, said in a note.

    Investors in coming weeks will be focused on how tariff rates ultimately settle and whether Trump’s trade policy might reignite inflation.

    “It would help stocks if we were to see a narrative shift from a focus on tariff, trade policy and geopolitics to company fundamentals,” Carol Schleif, chief market strategist, BMO Private Wealth, said in a note.

    Despite the rally, the ratio of bullish versus bearish outlooks for the market remains below the historical average, Ed Yardeni, president of Yardeni Research, said in a note.

    “That suggests more upside for the stock market since many investors remain wary and are not overly bullish,” Yardeni said.

    “Greed” was the sentiment driving the market on Thursday, according to CNN’s Fear and Greed index. It was the highest reading on the index in two weeks.

    Screenshot 2025 06 29 at 12.04.03 AM

    Dollar stumbles to three-year low

    The US dollar on Thursday dropped to its lowest level since February 2022 after a report by the Wall Street Journal that Trump plans to announce his pick for Federal Reserve Chair Jerome Powell’s successor as early as this fall.

    Powell’s term ends in May 2026, meaning there would effectively be a “shadow” Fed chair in the months before his term expires.

    The US dollar index, which measures the dollar’s strength against six major foreign currencies, was down 0.45% as of the afternoon.

    “A candidate who is perceived as being more open to lowering rates in line with President Trump’s demands would reinforce the US dollar’s current weakening trend,” Lee Hardman, senior currency analyst at MUFG, said in a note.

    The dollar index has tumbled nearly 10% this year. The euro and British pound this year have both hit their highest levels against the dollar in four years.

    Francesco Pesole, an FX strategist at ING, told The NYBudgets that concerns about the Fed’s independence have been one of the contributing factors to the dollar’s broad decline this year.

    “One of the key foundations of the strong dollar, of the dollar as a dominant currency globally, is to have an independent central bank,” Pesole said. “So, if [global investors] feel there is greater influence of politics into the Fed’s decisions, then they are pricing in a greater risk for the dollar.”

    Greg Valliere, chief US policy strategist at AGF Investments, said in a note that Trump announcing Powell’s successor is a “terrible idea,” as it would be “sure to annoy and confuse the financial markets if there are two Fed chairs.”

    “The damage to the Fed’s independence would be considerable if Trump becomes a monetary back-seat driver, second-guessing Fed policies this fall,” Valliere said.

  • S&P 500 nears bear market, as highest tariffs in a century threaten trade

    S&P 500 nears bear market, as highest tariffs in a century threaten trade

    The stock market staged a brief rally Tuesday on hopes that President Donald Trump would turn from raising tariffs to cutting deals, before sinking amid renewed tough talk by administration officials. The S&P 500 index closed down 1.5 percent, bringing its total loss since the mid-February start of Trump’s trade offensive to almost 20 percent, the official indication of a bear market.

    Stocks jumped nearly 4 percent in the first hour of trading, after Treasury Secretary Scott Bessent told CNBC that nearly 70 countries had approached the United States about negotiating over trade barriers. The next escalation of U.S. tariffs was just hours away. But the president fueled the upbeat mood with a subsequent social media post, describing a “great call” with South Korea’s acting president about a potential bargain.

    Yet the market rebound soon fizzled.

    On Capitol Hill, some of the president’s top aides sought to clarify the trade war’s murky parameters.

    Jamieson Greer, the president’s chief trade negotiator, described the nation’s $1.2 trillion trade deficit as an emergency that required “urgent” efforts to reshape the U.S. economy. Greer brushed aside lawmakers’ complaints about potential costs to consumers and businesses, telling the Senate Finance Committee, “The president is fixed in his purpose.”

    Bessent, meanwhile, sought to calm Republican fears that Trump’s bare-knuckled assault on the global trading system might trigger a politically lethal recession. During an hour-long meeting hosted by House Majority Whip Tom Emmer (R-Minnesota), Bessent briefed lawmakers and Jay Timmons, the head of the National Association of Manufacturers, on the administration’s plans for a manufacturing revival.

    One week after Trump’s announcement of the highest import taxes in more than a century, investors, companies and lawmakers continue trying to make sense of his ultimate goal. For now, the administration says the president is advancing on twin tracks: raising tariffs to encourage manufacturers to return to the United States, while fielding offers by other nations to lower their barriers to U.S. products.

    Despite swelling criticism from lawmakers and chief executives, the administration appears vindicated by the eagerness of foreign leaders hoping to avert U.S. tariffs by making a deal with Trump. In her daily briefing for reporters, White House press secretary Karoline Leavitt struck a combative tone.

    “America does not need other countries as much as other countries need us,” she said.

    The president’s high-risk strategy is already paying off, according to Greer, who cited recent investment announcements by automakers and other manufacturers planning to expand their U.S. operations. Likewise, officials from Argentina, Vietnam and Israel have indicated they will drop their tariff and regulatory barriers to U.S. exports.

    Greer and other administration officials are engaged in talks with countries such as Japan and South Korea.

    But there is no immediate prospect of talks with the nation at the center of U.S. trade complaints: China. After China imposed a 34 percent tariff on U.S. goods, in retaliation for Trump’s April 2 announcement, the president added an additional 50 percent tax on top of his earlier moves.

    As of 12:01 a.m. Wednesday, American importers of some Chinese products will pay a tax of up to 129 percent.

    Greer said the administration was “disappointed” with China’s failure to comply with the 2020 “phase one” trade deal Trump signed in his first term, which committed Beijing to make substantial purchases of U.S. farm, energy and manufactured goods. Amid the disruption of the pandemic, which erupted within weeks of the White House signing ceremony for the deal, China fell short of its commercial promises.

    After Trump said he would impose the additional 50 percent tariff, China’s Commerce Ministry called the president’s move “a mistake on top of a mistake.” If the United States waged a trade war against China, it would “fight to the end,” the ministry said.

    Administration official say they have the advantage over Chinese President Xi Jinping, since Americans buy roughly three times as much from China as the Chinese buy from U.S. companies. Trump said China “panicked” in opting to retaliate for his tariffs.

    “The president believes that Xi and China want to make a deal. They just don’t know how to get that started,” Leavitt told reporters.

    The administration’s unruly nature, however, is shadowing the president’s policy aims. Growing acrimony between Elon Musk, the world’s richest man, and Peter Navarro, a White House trade adviser, spilled into public view in recent days.

    After Navarro disparaged Musk during a CNBC interview as a “car assembler” rather than a manufacturer, the Tesla CEO savaged the former university professor in posts on X as “dumber than a sack of bricks” and “Peter Retarrdo.”

    The extraordinary display was praised by Leavitt as evidence of the administration’s transparency.

    “Boys will be boys, and we will let their public sparring continue,” she said.

    Greer’s congressional testimony offered additional details of Trump’s plan. Asked by several senators whether American businesses would win exclusions from the tariffs to continue importing products that they could not obtain from domestic suppliers, Greer said no.

    “The president does not intend to have exclusions,” he said, adding that granting them would undermine the planned economic restructuring. “We’re trying to remedy a situation that’s persisted for many years.”

    Though quick to praise the president’s goals, Republicans on the Finance Committee repeatedly voiced worry over the short-term economic costs.

    Sen. James Lankford (R-Oklahoma) told Greer a constituent had relocated his supply chain from China to Vietnam in response to the president’s first-term trade policy only to find that he would now be paying a new 46 percent tariff on Vietnamese products.

    Cattle ranchers in Montana were distressed by a 92 percent decline in Chinese purchases of U.S. beef last month, as the trade war intensified, according to Sen. Steve Daines (R-Montana).

    And Sen. Thom Tillis (R-North Carolina) pronounced himself “skeptical” that the administration could wage a trade war against dozens of countries simultaneously.

    “This is creating some anxiety,” said Sen. Todd Young (R-Indiana).

    Some big-name tech stocks with notable morning gains joined the broader market in retreating, with Alphabet, Amazon, Apple and Tesla in negative territory Tuesday afternoon.

    Stock analysts characterized Tuesday morning’s rally as a natural reaction after weeks of declines, capped by the harshest three-day sell-off in years.

    With tariff negotiations beginning, markets “may be an important step closer to finding an equilibrium,” Mark Zabicki, chief investment officer at LPL Financial, wrote in a Tuesday research note.

    Some Asian and European markets recovered Tuesday despite the Chinese threats of trade war escalation.

    Germany’s DAX gained about 2.5 percent, and London’s FTSE 100 climbed 3.3 percent. Japan’s Nikkei 225 jumped 6 percent, while Hong Kong’s Hang Seng Index and India’s Sensex were both up 1.5 percent.

    But markets in several Southeast Asian countries, which are vulnerable to any disruption of global trade, suffered more losses. Markets in Vietnam and Indonesia declined more than 7 percent, while an index linked to Thailand was down more than 4 percent. Taiwan’s Taiex fell 4 percent.